Additional Screening Forms in Assessments
With this enhancement in the CureMD application, additional screening forms have been added to assessments. This helps users evaluate the severity of patient’s condition.
With this enhancement in the CureMD application, additional screening forms have been added to assessments. This helps users evaluate the severity of patient’s condition.
With this enhancement, users can now view the procedure level information on the printed report of a pending problematic appointment in the problem list section. This ensures that complete (appointment level and procedure level) information is displayed on the printed report and shared with concerned parties for resolution.
With this enhancement in the CureMD application, users can download and install version 6.0 of CureMD Client Utility containing the latest updates. The updates enhance the security and performance of the utility.
Patient tags have been introduced in the Chemotherapy Manager to ensure that all patient tags relevant to a patient profile are displayed in the chemotherapy manager. This enhancement helps in compiling the information when the user looks up a patient, an order or an admin by leveraging the relevant tags.
Following are the enhanced areas in this feature:
With this enhancement, the system supports the latest versions of the American Joint Committee on Cancer (AJCC) cancer staging (versions 8 and 9). This ensures that through the AJCC cancer staging, the healthcare professionals have the ability to document the clinical data related to a patient's cancer stage.
Enhancements have been made to the Adverse Events Module in the Chemotherapy Manager including Resolution Reason for Adverse Event, Serious Adverse Event and Relationship Section.
In line with new CMS guidelines effective July 1, 2023, healthcare practices need to use the JZ modifier when billing for drugs, specifically when no amount is discarded from a single-dose container. This requirement applies to all such claims that are submitted by the practices. Hence, to ensure that the billing process complies with this requirement, JZ modifier has been introduced to the Chemotherapy Manager.
With this enhancement, practices have the ability to set precise limits for Serum Creatinine values and Creatinine Clearance levels when determining AUC-based drug dosing. By customizing these limits, healthcare providers can ensure personalized and effective patient care.
With this enhancement, Practice's Fax number and Supervising Provider’s name is displayed on the printed radiology requisition from Treatment Plan. This enhancement ensures that the both the ordering and supervising providers are identified.
An enhancement has been incorporated into the Labs Beta View, which allows the users to send multiple lab results Via email or fax directly from the Labs Beta View. This enables the users to send as many lab results as they want via email and fax mediums directly from the beta view, ensuing maximum flexibility and convenience.